Post-COVID care centres to open in district ayurveda hospitals in Rajasthan

IMT News Desk
IMT News Desk
· 2 min read

Experts will treat the patients who have recovered from the infection at these centres through homoeopathic, ayurvedic and Unani medical systems

Rajasthan Health Minister Raghu Sharma said that post-COVID care centres will be opened at all the district Ayurveda hospitals.

Experts will treat the patients who have recovered from the infection at these centres through homoeopathic, ayurvedic and Unani medical systems.

Sharma was addressing the advisory committee of Ayurveda, homoeopathic, Unani, yoga and naturopathy departments at Swasthya Bhawan in Jaipur.

Looking at the huge potential of medical tourism in the state, the minister said 20 such places have been identified in the state where there is the maximum movement of tourists. He said that a yoga centre with state-of-the-art-facilities will be opened at these places in public-private partnership (PPP) model.

Sharma claimed that the entire world believed in the AYUSH system during the coronavirus period. While no medical treatment was discovered in any medical system, positive results started coming out of the Ayurveda medical system, he said.

The government is committed for conservation and promotion of ayurveda, homoeopathic and Unani medical systems and is working for its betterment, Sharma added.

Sharma, who is also the Ayurveda Minister, directed officials to draw up a framework to develop botanical gardens at 17 places across the state and suggested that it could be done under the PPP model.

In the meeting, he gave instructions to develop these botanical gardens with the help of farmers and by deploying Dravyaguna (study of medicinal herbs and drugs) science experts at these places. He also mentioned about 10 types of medicinal plants at each AYUSH hospital with emphasis on planting guggal, tulsi, giloy, ashwagandha, arjun and other plants.

Sharma also directed officials to publish a booklet of major ayurvedic medicines with detailed explanation. National Institute of Ayurveda former director Professor Mahesh Chandra Sharma has taken the responsibility to prepare this booklet.

PTI

Read Next

Ministry of Ayush approves CoroQuil-Zn by Remedium Therapeutics
COVID-19
October 3, 2024

Ministry of Ayush approves CoroQuil-Zn by Remedium Therapeutics

The drug is enriched with potent herbs and zinc and offers a supportive approach to assist patients during their recovery from  COVID-19 The Ministry of Ayush, Government of India, recently approved CoroQuil-Zn, an herbal drug developed by Remedium Therapeutics in collaboration with Delhi Pharmaceutical Sciences and Research University, as an add-on treatment for mild and moderate […]
Article by: IMT News Desk
CrisprBits’ OmiCrisp tracks Omicron-derived JN.1 variant in sewage samples in Bengaluru
COVID-19
February 8, 2024

CrisprBits’ OmiCrisp tracks Omicron-derived JN.1 variant in sewage samples in Bengaluru

The test is currently being used to monitor sewage samples in 14 localities in Bengaluru Bengaluru-based startup CrisprBits has developed OmiCrisp, a CRISPR-based testing platform for rapid diagnosis and surveillance of SARS-CoV2. The CRISPR-based test not only detects the virus but also distinguishes variants of the Omicron lineage from other previously known variants of concern.  […]
Article by: IMT News Desk
Govt launches India’s first mRNA vaccine developed by Gennova
COVID-19
June 26, 2023

Govt launches India’s first mRNA vaccine developed by Gennova

GEMCOVAC -OM, an Omicron-specific mRNA-based booster vaccine has funding support from DBT & BIRAC Union Minister of State (Independent Charge) for Science and Technology, MoS PMO, Department of Atomic Energy and Department of Space and MoS Personnel, Public Grievances and Pensions, Dr Jitendra Singh launched the GEMCOVAC -OM, an Omicron-specific mRNA-based booster vaccine. India’s first […]
Article by: IMT News Desk
India’s first mRNA-based Omicron-specific booster vaccine from Gennova gets DCGI approval
COVID-19
June 21, 2023

India’s first mRNA-based Omicron-specific booster vaccine from Gennova gets DCGI approval

GEMCOVAC-OM is a lyophilised (freeze-dried) vaccine, stable at 2- 8 °C Pune-based Gennova Biopharmaceuticals announced that its mRNA COVID-19 booster vaccine – GEMCOVAC-OM – against the Omicron variant of SARS-CoV-2 received Emergency Use Authorization (EUA) from the office of the Drugs Controller General of India (DCGI). GEMCOVAC-OM is the first booster COVID-19 vaccine developed in India against […]
Article by: IMT News Desk